Banzai International (NASDAQ:BNZI – Get Free Report) had its target price decreased by Ascendiant Capital Markets from $30.00 to $26.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock.
Banzai International Trading Down 2.9 %
NASDAQ:BNZI opened at $1.00 on Monday. Banzai International has a 1 year low of $0.73 and a 1 year high of $20.50. The firm has a 50 day moving average of $1.14 and a 200-day moving average of $1.62.
Institutional Investors Weigh In On Banzai International
A hedge fund recently bought a new stake in Banzai International stock. Two Sigma Securities LLC bought a new stake in Banzai International, Inc. (NASDAQ:BNZI – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 27,730 shares of the company’s stock, valued at approximately $42,000. Two Sigma Securities LLC owned 0.47% of Banzai International as of its most recent SEC filing. 96.82% of the stock is currently owned by institutional investors and hedge funds.
Banzai International Company Profile
Banzai International, Inc, a marketing technology company, provides data-driven marketing and sales solutions for various businesses in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its products include Demio, a browser-based webinar platform with data and marketing features designed to help businesses engage with their audience through live events and on-demand, interactive video content; Boost, a software-as-a-service (SaaS) solution for social sharing by event registrants; and Reach, a SaaS and managed service to increase registration and attendance of marketing events.
See Also
- Five stocks we like better than Banzai International
- How to Buy Gold Stock and Invest in Gold
- These 3 ETFs Let You Hold Real Gold Without the Vault
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Why Institutions Are Buying Super Micro Computer Stock Again
- The Significance of Brokerage Rankings in Stock Selection
- 3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.
Receive News & Ratings for Banzai International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Banzai International and related companies with MarketBeat.com's FREE daily email newsletter.